|
|
|
|
|
Session 93
Poster Presentations Dyslipidemia Associated with Antiretroviral Therapy Session Day and Time: Thursday 1:30 - 3:30 pm Room: Hall B |
Background:
Alterations in serum lipids after initiation of highly active antiretroviral
therapy (HAART) have been widely reported. Limited data are available to
evaluate the relative effect of HIV-1 infection and antiretroviral therapy
(ART) on these lipid abnormalities.
Methods:
Longitudinal analysis of data and sera from HIV-infected men in the Multicenter
AIDS Cohort Study (MACS) were performed to describe changes in serum lipids
during the course of HIV-1 infection and during treatment with ART. Mean levels
of total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low
density lipoprotein cholesterol (LDL-C), apolipoprotein A (ApoA), and
apolipoprotein B (ApoB) were measured 1) at 5 time-points for 50 men who were
HIV-seroconverters (SC) and later initiated HAART (pre-SC, pre-HAART, and 3
time-points post-HAART), and 2) at 2 time-points for 496 seroprevalent (SP)
HIV-infected men who initiated either mono-or combination ART (n = 291) and/or
HAART (n = 205).
Results: Prior to
HIV-1 infection, the mean TC, HDL-C and LDL-C for the 50 SC were similar to
NHANES III for adult men. After HIV-infection (mean 7.8 ±2.6 yrs), notable
declines in TC (-31 mg/dL, 95% CI: -51, -19), HDL-C (-12 mg/dL, 95% CI: -18,
-6), LDL-C (-21 mg/dl, 95% CI: -44, 4) and
Conclusions:
HIV-infection results in reductions in TC, HDL-C, and LDL-C. HAART initiation
is associated with increases in TC and LDL-C, but not HDL-C. The increase in TC
(20 mg/dl) seen after HAART (11.6 yrs after pre-SC baseline) in our 50 SC men
is commensurate with aging (NHANES III). In this cohort, the majority of the
increase in TC and LDL-C observed after approximately 3 yrs of HAART appears to
represent a return to pre-infection serum lipid levels in combination with an
expected increase due to aging; however, longer follow up is needed.